EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Prime Editing: An Emerging Tool in Cancer Treatment

Debmitra Sen, Sutripta Sarkar iD, Poulami Mukhopadhyay

Molecular Biotechnology · 2023-04 · 65 (4) · 509-520

DOI: 10.1007/s12033-022-00580-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, online erschienen am 17.10.2022. Verfasst von Debmitra Sen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Barrackpore Rastraguru Surendranath College, Kolkata, West Bengal, 700120, India. Hauptthemen laut MEDLINE: Gene Editing, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prime Editing is a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) based genome editing technique having promising potential in terms of reducing off target activity. It introduces fragments of DNA sequences into the target site using a guide RNA (gRNA) molecule, composed of both the sequence that is to be inserted into the target site along with an inactive Cas9 nickase and a reverse transcriptase. Prime Editing can cause insertions, deletions, and various point mutations for reverting the phenetic characteristics of a disease specially tested in human adult stem cells and cancer cell lines. The main aim of our review is to explore how Prime Editing and its various forms are being utilized as an emerging tool to cure deleterious diseases like cancer, also as a delivery strategy of the tool into cells. There are almost five generations of Prime Editors (PE) with increasing levels of efficiency from one level to another that have huge clinical potential in correcting mutations; however, the necessity for a pegRNA design is extremely significant. But besides having such advantages, the limitations of this technology particularly include generation of double nicks while optimizing the efficiency of PE3. So, it is important to consider all such consequences and customize PE as per requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingNeoplasmsHumansMutationCRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPRCancerPrime EditingPrime EditorspegRNA

Autor:innen und Institutionen

  • Department of Microbiology, Barrackpore Rastraguru Surendranath College, Kolkata, West Bengal, 700120, India.
  • Department of Microbiology, University of Kalyani, Nadia, 741235, India.
  • Department of Food and Nutrition, Barrackpore Rastraguru Surendranath College, Kolkata, West Bengal, 700120, India.
  • Department of Microbiology, Barrackpore Rastraguru Surendranath College, Kolkata, West Bengal, 700120, India. pmpoulami.6@gmail.com.

ORCID-Profile: Sutripta Sarkar

Zitieren

APA

Sen, D., Sarkar, S., & Mukhopadhyay, P. (2023). Prime Editing: An Emerging Tool in Cancer Treatment. Molecular Biotechnology, 65(4), 509-520. https://doi.org/10.1007/s12033-022-00580-3

Vancouver

Sen D, Sarkar S, Mukhopadhyay P. Prime Editing: An Emerging Tool in Cancer Treatment. Molecular Biotechnology. 2023;65(4):509-520. doi:10.1007/s12033-022-00580-3

BibTeX
@article{Sen2023,
  author = {Sen, Debmitra and Sarkar, Sutripta and Mukhopadhyay, Poulami},
  title = {Prime Editing: An Emerging Tool in Cancer Treatment},
  journal = {Molecular Biotechnology},
  year = {2023},
  volume = {65},
  number = {4},
  pages = {509--520},
  doi = {10.1007/s12033-022-00580-3}
}
Kostenlos starten →